Literature DB >> 1590314

Evidence for colonic conservation of malabsorbed carbohydrate in short bowel syndrome.

D Royall1, T M Wolever, K N Jeejeebhoy.   

Abstract

The purpose of this study was to determine whether energy from malabsorbed carbohydrate could be conserved through colonic fermentation in short bowel syndrome. Seven patients with short bowel anastomosed to the remaining colon and five patients with short bowel without a colon were selected from the home total parenteral nutrition (TPN) program. Six normal volunteers also were studied. After an overnight fast, subjects consumed a 50-g carbohydrate bread meal and were studied hourly over the next 6 h. Carbohydrate malabsorption, estimated by lactulose breath hydrogen testing, was 48 +/- 13% in short bowel patients. After the bread meal, breath hydrogen was higher in short bowels with colons (69 +/- 20 ppm) than in either short bowels without colons (11 +/- 7 ppm) or normal subjects (10 +/- 3 ppm) (p less than 0.01). Blood acetate levels also were higher in short bowels with colons than in those without colons, reaching a peak of 167 +/- 27 mumol/L at 4 h (p less than 0.05). We conclude that in patients with a short bowel and a colon, malabsorbed carbohydrate is fermented and there is a rise in blood acetate, suggesting that the colon has a role in salvaging malabsorbed carbohydrate as a source of energy through carbohydrate fermentation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1590314

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  10 in total

Review 1.  Nutritional modulation of the inflammatory response in inflammatory bowel disease--from the molecular to the integrative to the clinical.

Authors:  Gary E Wild; Laurie Drozdowski; Carmela Tartaglia; M Tom Clandinin; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

Review 2.  Where are we at with short bowel syndrome and small bowel transplant.

Authors:  Baris Dogu Yildiz
Journal:  World J Transplant       Date:  2012-12-24

3.  Importance of colonic bacterial fermentation in short bowel patients: small intestinal malabsorption of easily digestible carbohydrate.

Authors:  M Olesen; E Gudmand-Høyer; J J Holst; S Jørgensen
Journal:  Dig Dis Sci       Date:  1999-09       Impact factor: 3.199

4.  Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomised, double blind, crossover, placebo controlled study.

Authors:  J Szkudlarek; P B Jeppesen; P B Mortensen
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

5.  Comparison of inulin and lactulose as reference standards in the breath hydrogen test assessment of carbohydrate malabsorption in patients with chronic pancreatic exocrine insufficiency.

Authors:  P M O Owira; G O Young; T A Winter
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

Review 6.  Host-Gut Microbiota Crosstalk in Intestinal Adaptation.

Authors:  Justine Marchix; Gillian Goddard; Michael A Helmrath
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-02-15

7.  The role of intestinal transplantation in the management of intestinal failure.

Authors:  J P Fryer
Journal:  Curr Gastroenterol Rep       Date:  2001-08

Review 8.  Liver disease secondary to intestinal failure.

Authors:  Bassam Abu-Wasel; Michele Molinari
Journal:  Biomed Res Int       Date:  2014-01-15       Impact factor: 3.411

Review 9.  Extensive Intestinal Resection Triggers Behavioral Adaptation, Intestinal Remodeling and Microbiota Transition in Short Bowel Syndrome.

Authors:  Camille Mayeur; Laura Gillard; Johanne Le Beyec; André Bado; Francisca Joly; Muriel Thomas
Journal:  Microorganisms       Date:  2016-03-08

Review 10.  Gastroesophageal Reflux Disease and Foregut Dysmotility in Children with Intestinal Failure.

Authors:  Anna Rybak; Aruna Sethuraman; Kornilia Nikaki; Jutta Koeglmeier; Keith Lindley; Osvaldo Borrelli
Journal:  Nutrients       Date:  2020-11-18       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.